We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+10.82%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$48.6B
AUM Growth
+$3.08B
Cap. Flow
+$3.24M
Cap. Flow %
0.01%
Top 10 Hldgs %
13.89%
Holding
3,030
New
136
Increased
1,065
Reduced
1,247
Closed
140

Sector Composition

Rank Sector Weight
1 Technology 18.34%
2 Healthcare 14.16%
3 Financials 13.97%
4 Real Estate 9.14%
5 Consumer Discretionary 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMVP icon
2726
PMV Pharmaceuticals
PMVP
$69.3M
$13.8K ﹤0.01%
1,592
RGR icon
2727
Sturm, Ruger & Co
RGR
$598M
$13.8K ﹤0.01%
+273
New +$14.8K
IDYA icon
2728
IDEAYA Biosciences
IDYA
$3.55B
$13.4K ﹤0.01%
735
CDTX
2729
DELISTED
Cidara Therapeutics
CDTX
$12.9K ﹤0.01%
855
LCII icon
2730
LCI Industries
LCII
$2.61B
$12.8K ﹤0.01%
138
STOK icon
2731
Stoke Therapeutics
STOK
$2.13B
$12.8K ﹤0.01%
1,382
GH icon
2732
Guardant Health
GH
$22.2B
$12.5K ﹤0.01%
458
EGIO
2733
DELISTED
Edgio, Inc. Common Stock
EGIO
$12.3K ﹤0.01%
272
IPSC icon
2734
Century Therapeutics
IPSC
$372M
$12.2K ﹤0.01%
2,375
KOD icon
2735
Kodiak Sciences
KOD
$2.64B
$11.3K ﹤0.01%
1,572
SPRO icon
2736
Spero Therapeutics
SPRO
$71.2M
$11.1K ﹤0.01%
6,400
GLUE icon
2737
Monte Rosa Therapeutics
GLUE
$1.34B
$10.9K ﹤0.01%
1,431
CRBU icon
2738
Caribou Biosciences
CRBU
$168M
$10.8K ﹤0.01%
1,716
RAPT
2739
DELISTED
RAPT Therapeutics
RAPT
$10.8K ﹤0.01%
68
LBRDA icon
2740
Liberty Broadband Class A
LBRDA
$5.33B
$10.6K ﹤0.01%
140
DSGN icon
2741
Design Therapeutics
DSGN
$915M
$10.2K ﹤0.01%
992
INSM icon
2742
Insmed
INSM
$29B
$10.1K ﹤0.01%
505
-105,841
-100% -$2.05M
WES icon
2743
Western Midstream Partners
WES
$19.9B
$9.34K ﹤0.01%
348
APAM icon
2744
Artisan Partners
APAM
$3.08B
$8.97K ﹤0.01%
302
COUR icon
2745
Coursera
COUR
$1.5B
$8.88K ﹤0.01%
751
EVBN
2746
DELISTED
Evans Bancorp Inc
EVBN
$8.41K ﹤0.01%
225
+147
+188% +$5.5K
GBIO
2747
DELISTED
Generation Bio
GBIO
$8.12K ﹤0.01%
207
-2,113
-91% -$111K
CZFS icon
2748
Citizens Financial Services
CZFS
$396M
$7.34K ﹤0.01%
99
CVAC
2749
DELISTED
CureVac
CVAC
$7.3K ﹤0.01%
1,205
VERU icon
2750
Veru
VERU
$47.6M
$7.1K ﹤0.01%
134

Similar funds

Russell Investments Group's Q4 2022 Portfolio in Review

As of Q4 2022, Russell Investments Group held 3,030 positions worth $48.6B, up 6.8% from $45.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Russell Investments Group's Q4 2022 filing shows 136 new, 1,065 increased, 1,247 reduced and 140 closed positions. Its largest new stake was Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock: 940,000 shares worth $791K. The largest sale was Duke Realty Corp., an estimated $109M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Russell Investments Group's largest Q4 2022 buy was Sabre Corporation 6.50% Series A Mandatory Convertible Preferred Stock: 940,000 shares worth $791K.
  • Russell Investments Group added most to Bank of America Series L in Q4 2022, an estimated $806M increase.
  • Russell Investments Group's biggest Q4 2022 reduction was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A, cutting an estimated $80.1M.
  • Russell Investments Group fully exited Duke Realty Corp. in Q4 2022, selling an estimated $109M.
  • Russell Investments Group's ten largest holdings make up 14% of its $48.6B portfolio in Q4 2022.
  • Russell Investments Group opened 136 new positions and closed 140 in Q4 2022.
  • Russell Investments Group's portfolio value rose 6.8% quarter-over-quarter to $48.6B.

Based on Russell Investments Group's 13F filing for Q4 2022, filed 8 Feb 2023.